Clinical Trials Browser

Phase 2 × Antibodies, Monoclonal × Breast × Clear all

NCT01873833 2023-10-05

Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer

Phase 2 Terminated

10 enrolled 16 charts

Breast Neoplasms